For IM injections, the needle should enter the muscle fully at a 90-degree angle (typically 1 to 1.5 inches, depending on body composition)
Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8
In this category, disorders include Crohns disease, Coeliac disease, and previous gastric surgery that interfere with the absorption of B12
Rotating injection sites prevents chronic irritation
Some of the preclinical research has included preliminary results for: Inflammatory bowel disease: In mouse studies, KPV reduced inflammation and protected the gut barrier